PMFA
INSM icon

Plante Moran Financial Advisors’s Insmed INSM Stock Holding History

Plante Moran Financial Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$720 – 858
2025
Q3 		$720 Buy
+5
New +$613 ﹤0.01% 716

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Plante Moran Financial Advisors's INSM Position: Q4 2025 in Review

Plante Moran Financial Advisors sold out of Insmed (INSM) in Q4 2025, closing a stake of 5 shares — an estimated $720 sold.

Plante Moran Financial Advisors first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $720 in Q3 2025. 677 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Plante Moran Financial Advisors reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 5 Insmed shares in Q4 2025, an estimated $720.
  • Plante Moran Financial Advisors first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Insmed position peaked at $720 in Q3 2025.
  • 677 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.